-+ 0.00%
-+ 0.00%
-+ 0.00%

XERIS BIOPHARMA HOLDINGS INC. :  BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $9

Reuters·12/09/2025 11:33:28

Please log in to view news